| A Study of Mitoxantrone Hydrochloride Liposome Injection for Relapsing Multiple Sclerosis (NCT05496894) | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 2022-08-01 |
| PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery (NCT05468138) | Fudan University | 2022-08-01 |
| Fluzoparib and Apatinib Versus Fluzoparib in Relapsed Ovarian Carcinoma Maintenance Treatment (NCT05479487) | Xiaohua Wu MD | 2022-08-01 |
| Irinotecan, TAS-102 Plus Bevacizumab as a Third-Line or Beyond Therapy in mCRC Patients (NCT06403709) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2022-08-01 |
| Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma (NCT05303727) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2022-08-01 |
| Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (NCT05660473) | Institute of Hematology & Blood Diseases Hospital, China | 2022-08-01 |
| Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD (NCT04968938) | Resilient Pharmaceuticals | 2022-08-01 |
| Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients (NCT05375994) | Verastem, Inc. | 2022-08-01 |
| Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction (NCT05388825) | Vigonvita Life Sciences | 2022-08-01 |
| The Effects of Mesenchymal Stem Cell Secretome in Rheumatoid Arthritis Patients (NCT05925647) | Universitas Sebelas Maret | 2022-08-01 |
| A Study of MTPS9579A in Participants With Refractory Chronic Spontaneous Urticaria (NCT05129423) | Genentech, Inc. | 2022-07-31 |
| Afatinib in Advanced NRG1-Rearranged Malignancies (NCT04410653) | German Cancer Research Center | 2022-07-31 |
| Effect of Astaxanthin in Moderate to Severe Knee Osteoarthritis (NCT05437601) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2022-07-31 |
| A Study of MAX-40279combined With KN046 in Patients With Advanced / Metastatic Solid Tumors (NCT05425602) | Maxinovel Pty., Ltd. | 2022-07-31 |
| Treatment With Cannabis Oil Containing CBD, THC, CBDV or CBG vs. Placebo of Persons With ADHD (NCT05219370) | Brlev Agricultural Crops Ltd | 2022-07-31 |
| Clinical Assessment of 3 Differant Obturation Sealers on Postoprative Pain and Swelling (NCT05419752) | Cairo University | 2022-07-30 |
| Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDO (NCT05033756) | Institut fuer Frauengesundheit | 2022-07-30 |
| Tazemetostat for the Treatment of Relapsed/Refractory Follicular Lymphoma (NCT05467943) | Hutchmed | 2022-07-29 |
| A Phase 1/ 2, First-in-Human, Open-Label, Accelerated-Titration, Two-Part Clinical Trial of TK-8001 in Patients With HLA-A*02:01 Genotype and Advanced-Stage/ Metastatic MAGE-A1+ Solid Tumors (NCT05430555) | T-knife GmbH | 2022-07-29 |
| Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy (NCT05415917) | Rutgers, The State University of New Jersey | 2022-07-29 |
| Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF (NCT05389215) | Daewoong Pharmaceutical Co. LTD. | 2022-07-29 |
| Nesvategrast (OTT166) in Diabetic Retinopathy (DR) (NCT05409235) | OcuTerra Therapeutics, Inc. | 2022-07-29 |
| Biomarker-driven Intermittent Docetaxel in Metastatic Castration-resistant Prostate Cancer (NCT04918810) | Australian and New Zealand Urogenital and Prostate Cancer Trials Group | 2022-07-29 |
| A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 with Valganciclovir (VGCV) in Subjects with Hepatocellular Carcinoma (NCT05595473) | Rznomics, Inc. | 2022-07-29 |
| CONFOCAL-2 Interventional Pilot Study (NCT07296029) | Queen's University | 2022-07-29 |
| A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer (NCT05379595) | Janssen Research & Development, LLC | 2022-07-29 |
| An Open Label Study That Will Test Safety and Efficacy of RZL-012 Injection Into the Submental Fat in Chinese vs. Non-Chinese Subjects. (NCT05466448) | Raziel Therapeutics Ltd. | 2022-07-29 |
| FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients (NCT05727163) | Sun Yat-sen University | 2022-07-29 |
| Impact of CardiolRx on Myocardial Recovery in Patients With Acute Myocarditis (NCT05180240) | Cardiol Therapeutics Inc. | 2022-07-28 |
| Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria Flares (NCT05496465) | ARS Pharmaceuticals, Inc. | 2022-07-28 |
| Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer (NCT05167409) | University of Colorado, Denver | 2022-07-28 |
| Neoadjuvant Breast Cancer Time Restricted Eating (NCT05327608) | Thomas Jefferson University | 2022-07-28 |
| Olanzapine in OUD Patients (NCT05179772) | University of Pennsylvania | 2022-07-28 |
| Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma (NCT05363670) | ARS Pharmaceuticals, Inc. | 2022-07-28 |
| Butyrate Adjuvant Therapy for Type 1 Diabetes (NCT03999853) | Mayo Clinic | 2022-07-28 |
| Daily Topical Rapamycin for Vitiligo (NCT05342519) | Medical University of South Carolina | 2022-07-28 |
| Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation (NCT05285878) | The Methodist Hospital Research Institute | 2022-07-28 |
| Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy (NCT06870942) | Shanghai Zhongshan Hospital | 2022-07-28 |
| BI-1607 in Combination with Trastuzumab in Subjects with HER2-positive Advanced Solid Tumors (NCT05555251) | BioInvent International AB | 2022-07-28 |
| To Evaluate OBI-833/OBI-821 in Combination With First-Line Erlotinib in Patients With EGFR-Mutated, Globo H-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NCT05442060) | OBI Pharma, Inc | 2022-07-27 |
| A Placebo Controlled Trial of Acebilustat (CTX 4430) for the Treatment of Human Upper Extremity Lymphedema (NCT05203835) | Stanford University | 2022-07-27 |
| Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients (NCT04765514) | AHS Cancer Control Alberta | 2022-07-27 |
| A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A) (NCT05342636) | Merck Sharp & Dohme LLC | 2022-07-27 |
| Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships With Clinical Assessments. (NCT05124925) | Novartis Pharmaceuticals | 2022-07-27 |
| Hemodialysis.-Induced Hypotension Therapy for End Stage Kidney Disease (NCT05297786) | Vanderbilt University Medical Center | 2022-07-27 |
| A Phase II Study of HR070803 in the Treatment of Advanced Esophageal Cancer (NCT05425472) | Jiangsu HengRui Medicine Co., Ltd. | 2022-07-27 |
| Orelabrutinib With R-CHOP-like Regimen for Patients With Newly Diagnosed Untreated Non-GCB DLBCL (NCT05498259) | The First Affiliated Hospital of Soochow University | 2022-07-27 |
| Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-III (NCT05886829) | Dr. Ferrer BioPharma | 2022-07-27 |
| Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma (NCT06909877) | Haihe Biopharma Co., Ltd. | 2022-07-27 |
| Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above (NCT05404945) | University of Virginia | 2022-07-26 |
| Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (NCT05172258) | National Cancer Institute (NCI) | 2022-07-26 |
| Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis (NCT05382312) | GlaxoSmithKline | 2022-07-26 |
| Ortho-R® for Rotator Cuff Repair Compared With Standard of Care Rotator Cuff Repair Without Ortho-R® (NCT05333211) | ChitogenX Inc | 2022-07-26 |
| Study of KN046 in Subjects With Advanced Non-Small Cell Lung Cancer (NCT05420220) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2022-07-26 |
| Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma (NCT05422066) | Li Zhiming | 2022-07-26 |
| Cobimetinib In Extracranial Arteriovenous Malformations (COBI-AVM Study) (NCT05125471) | University of Arkansas | 2022-07-26 |
| A Study to Evaluate ENERGI-F703 GEL in Venous Leg Ulcer (NCT04078555) | Energenesis Biomedical Co., Ltd. | 2022-07-26 |
| A Study to Learn About New COVID-19 RNA Vaccine Candidates in COVID-19 Vaccine-Experienced Healthy Individuals (NCT05472038) | BioNTech SE | 2022-07-26 |
| Examining the Effects of Mitochondrial Oxidative Stress in DCM (NCT05410873) | Imperial College London | 2022-07-26 |
| AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer (NCT05377658) | Henan Cancer Hospital | 2022-07-26 |
| A Study to Assess the Efficacy, Safety, and Pharmacokinetics of TB006 in Participants With Acute Ischemic Stroke (NCT05156827) | TrueBinding, Inc. | 2022-07-26 |
| Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease (NCT05229614) | CNAO National Center of Oncological Hadrontherapy | 2022-07-26 |
| Dose Regimen Study of SLI-F06 in Healthy Volunteers (NCT05501327) | Scarless Laboratories, Inc. | 2022-07-25 |
| An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer (NCT05454488) | M.D. Anderson Cancer Center | 2022-07-25 |
| Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002) (NCT05446870) | Merck Sharp & Dohme LLC | 2022-07-25 |
| Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM (NCT05485909) | Sun Yat-sen University | 2022-07-25 |
| Phase 2a Trial to Evaluate Safety and Immunogenicity of COVID-19 Vaccine Strategies in HIV-infected/Uninfected Adults. (NCT05515042) | The Aurum Institute NPC | 2022-07-25 |
| A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. (NCT05335993) | CanariaBio Inc. | 2022-07-25 |
| Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye Disease (NCT05370495) | Seinda Pharmaceutical Guangzhou Corporation | 2022-07-25 |
| Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before Hepatectomy (NCT05442632) | Fudan University | 2022-07-25 |
| A Study to Evaluate Tislelizumab Combined With Sitravatinib as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection (NCT05407519) | Anhui Provincial Hospital | 2022-07-25 |
| Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma (NCT05315258) | University of Oxford | 2022-07-25 |
| The Efficacy and Safety of Topical Vitamin D Drop on Meibomian Gland Function in Patients With Meibomian Gland Dysfunction (NCT05495958) | Shahid Beheshti University of Medical Sciences | 2022-07-25 |
| Selinexor Plus VRd in High Risk Newly Diagnosed Multiple Myeloma (NCT05422027) | Xia Zhongjun | 2022-07-25 |
| Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma (NCT05366829) | Rutgers, The State University of New Jersey | 2022-07-25 |
| CardioRenal Effects of SGLT2 Inhibition in Kidney Transplant Recipients (NCT04906213) | Duke University | 2022-07-25 |
| Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer (NCT05364645) | SWOG Cancer Research Network | 2022-07-25 |
| REpurposing SirolimUS in Compensated Advanced Chronic Liver Disease. the RESUS Proof of Concept Study (NCT05663944) | Nottingham University Hospitals NHS Trust | 2022-07-25 |
| A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus) (NCT05583955) | Noema Pharma AG | 2022-07-25 |
| Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy (NCT05442710) | Artcline GmbH | 2022-07-24 |
| Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (NCT05633420) | Shin Poong Pharmaceutical Co. Ltd. | 2022-07-24 |
| A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease (NCT05242471) | Janssen Research & Development, LLC | 2022-07-22 |
| LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT05321420) | PureTech | 2022-07-22 |
| Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years (NCT05468736) | Novavax | 2022-07-22 |
| Screening Study for Participants With Malignant Tumors (NCT05419375) | Hoffmann-La Roche | 2022-07-22 |
| A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR) (NCT05436652) | Sparrow Pharmaceuticals | 2022-07-22 |
| Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer (NCT05044871) | Tongji Hospital | 2022-07-22 |
| Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Tislelizumab and Regorafenib as First-Line Therapy for Advanced Cholangiocarcinoma (NCT07619937) | The First Affiliated Hospital of Zhengzhou University | 2022-07-22 |
| A Study of Ingested Cannabidiol in Healthy Occasional Cannabis Users (NCT05407285) | Centre hospitalier de l'Université de Montréal (CHUM) | 2022-07-22 |
| CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy (NCT05291156) | University of Campania Luigi Vanvitelli | 2022-07-21 |
| A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies (NCT05032040) | Xencor, Inc. | 2022-07-21 |
| A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II) (NCT05371613) | Denali Therapeutics Inc. | 2022-07-21 |
| HAIC Combined With Tislelizumab and Apatinib for Unresectable Intrahepatic Cholangiocarcinoma (NCT05290116) | Yunfei Yuan | 2022-07-21 |
| A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer. (NCT05493995) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2022-07-21 |
| Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers (NCT04886531) | Ruth O'Regan | 2022-07-21 |
| Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25 (NCT06227676) | Cornell University | 2022-07-21 |
| Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia (NCT04968379) | American Regent, Inc. | 2022-07-21 |
| Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma (NCT05208307) | Emory University | 2022-07-21 |
| The Anti-Freaze-F Study- "Anti-TNF for Treatment of Frozen Shoulder - a Feasibility Study" (NCT05299242) | University of Oxford | 2022-07-21 |
| Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis (NCT05067348) | Tang-Du Hospital | 2022-07-21 |